TrialBMC cancer2014

Randomized controlled trial to evaluate the effects of ethyl-2-cyanoacrylate on pain intensity and quality of life in head and neck cancer patients suffering from cetuximab-induced rhagades during radioimmunotherapy: the support trial.

Karin Potthoff et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.